These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters. Sampath LA; Tambe SM; Modak SM Infect Control Hosp Epidemiol; 2001 Oct; 22(10):640-6. PubMed ID: 11776351 [TBL] [Abstract][Full Text] [Related]
4. Comparison of microbial adherence to antiseptic and antibiotic central venous catheters using a novel agar subcutaneous infection model. Gaonkar TA; Modak SM J Antimicrob Chemother; 2003 Sep; 52(3):389-96. PubMed ID: 12917250 [TBL] [Abstract][Full Text] [Related]
5. Chlorhexidine-silver sulfadiazine-impregnated central venous catheters: in vitro antibacterial activity and impact on bacterial adhesion. Monzillo V; Corona S; Lanzarini P; Dalla Valle C; Marone P New Microbiol; 2012 Apr; 35(2):175-82. PubMed ID: 22707130 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients. Carrasco MN; Bueno A; de las Cuevas C; Jimenez S; Salinas I; Sartorius A; Recio T; Generelo M; Ruiz-Ocaña F Intensive Care Med; 2004 Apr; 30(4):633-8. PubMed ID: 14722639 [TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of the antibacterial activity of three different central venous catheters against gram-positive bacteria. Yorganci K; Krepel C; Weigelt JA; Edmiston CE Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):379-84. PubMed ID: 12072923 [TBL] [Abstract][Full Text] [Related]
8. In vitro antimicrobial activity of a new antiseptic central venous catheter. Li C; Zhang X; Whitbourne R J Biomater Appl; 1999 Jan; 13(3):206-23. PubMed ID: 9934626 [TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters. Hanna H; Bahna P; Reitzel R; Dvorak T; Chaiban G; Hachem R; Raad I Antimicrob Agents Chemother; 2006 Oct; 50(10):3283-8. PubMed ID: 17005806 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of an antimicrobial-impregnated continuous ambulatory peritoneal dialysis catheter for infection control in rats. Kim CY; Kumar A; Sampath L; Sokol K; Modak S Am J Kidney Dis; 2002 Jan; 39(1):165-73. PubMed ID: 11774116 [TBL] [Abstract][Full Text] [Related]
11. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Heard SO; Wagle M; Vijayakumar E; McLean S; Brueggemann A; Napolitano LM; Edwards LP; O'Connell FM; Puyana JC; Doern GV Arch Intern Med; 1998 Jan; 158(1):81-7. PubMed ID: 9437382 [TBL] [Abstract][Full Text] [Related]
12. Double-lumen central venous catheters impregnated with chlorhexidine and silver sulfadiazine to prevent catheter colonisation in the intensive care unit setting: a prospective randomised study. Camargo LF; Marra AR; Büchele GL; Sogayar AM; Cal RG; de Sousa JM; Silva E; Knobel E; Edmond MB J Hosp Infect; 2009 Jul; 72(3):227-33. PubMed ID: 19443078 [TBL] [Abstract][Full Text] [Related]
13. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Maki DG; Stolz SM; Wheeler S; Mermel LA Ann Intern Med; 1997 Aug; 127(4):257-66. PubMed ID: 9265424 [TBL] [Abstract][Full Text] [Related]
14. Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria. Schmitt SK; Knapp C; Hall GS; Longworth DL; McMahon JT; Washington JA J Clin Microbiol; 1996 Mar; 34(3):508-11. PubMed ID: 8904403 [TBL] [Abstract][Full Text] [Related]
15. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. Darouiche RO; Raad II; Heard SO; Thornby JI; Wenker OC; Gabrielli A; Berg J; Khardori N; Hanna H; Hachem R; Harris RL; Mayhall G N Engl J Med; 1999 Jan; 340(1):1-8. PubMed ID: 9878638 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of antiadhesive, antibiotic and antiseptic coatings in preventing catheter-related infections: review. Donelli G; Francolini I J Chemother; 2001 Dec; 13(6):595-606. PubMed ID: 11806619 [TBL] [Abstract][Full Text] [Related]
17. Decreased bacterial adherence and biofilm formation on chlorhexidine and silver sulfadiazine-impregnated central venous catheters implanted in swine. Greenfeld JI; Sampath L; Popilskis SJ; Brunnert SR; Stylianos S; Modak S Crit Care Med; 1995 May; 23(5):894-900. PubMed ID: 7736748 [TBL] [Abstract][Full Text] [Related]
18. Prevention of bacterial colonization of intravenous catheters by antiseptic impregnation of polyurethane polymers. Bach A; Böhrer H; Motsch J; Martin E; Geiss HK; Sonntag HG J Antimicrob Chemother; 1994 May; 33(5):969-78. PubMed ID: 8089070 [TBL] [Abstract][Full Text] [Related]
19. Modification of central venous catheter polymers to prevent in vitro microbial colonisation. Tebbs SE; Elliott TS Eur J Clin Microbiol Infect Dis; 1994 Feb; 13(2):111-7. PubMed ID: 8013481 [TBL] [Abstract][Full Text] [Related]
20. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Rupp ME; Lisco SJ; Lipsett PA; Perl TM; Keating K; Civetta JM; Mermel LA; Lee D; Dellinger EP; Donahoe M; Giles D; Pfaller MA; Maki DG; Sherertz R Ann Intern Med; 2005 Oct; 143(8):570-80. PubMed ID: 16230723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]